MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
Expected by year-end 2026, the new solution brings the full range of MindMotion neurotherapeutic activities to a tablet-based format designed for easier deployment at home GENEVA, Sept. 17, 2026 /PRNewswire/ -- MindMaze Therapeutics (SIX: MMTX), a global leader in scalable precision...